# BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

> **NCT05557422** · — · COMPLETED · sponsor: **Becton, Dickinson and Company** · enrollment: 322 (actual)

## Conditions studied

- Chronic Lymphoproliferative Diseases (CLPD)

## Interventions

- **DIAGNOSTIC_TEST:** BD OneFlow LST, and B-CLPD T1 to T4 Assays

## Key facts

- **NCT ID:** NCT05557422
- **Lead sponsor:** Becton, Dickinson and Company
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-12
- **Primary completion:** 2024-05-08
- **Final completion:** 2024-05-08
- **Target enrollment:** 322 (ACTUAL)
- **Last updated:** 2024-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05557422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05557422, "BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05557422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*